Neurology
3 drugs are in development for Dravet Syndrome.
- Companies
- 3
- Clinical trials
- 15
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Dravet Syndrome pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| epidiolex | Jazz Pharmaceuticals plc (JAZZ) |
Phase 3(1)
| Drug | Company |
|---|---|
| Zorevunersen | BIOGEN INC. (BIIB) |
Phase 2(1)
| Drug | Company |
|---|---|
| zorevunersen | Stoke Therapeutics, Inc. (STOK) |
About this indication
Dravet Syndrome context
Neurology·MeSH: Epilepsies, Myoclonic (D004831)
Compare drugs
Frequently asked questions
How many drugs are in development for Dravet Syndrome?
BioSniper tracks 3 drugs in development for Dravet Syndrome across 3 companies.
How many clinical trials target Dravet Syndrome?
There are 15 clinical trials targeting Dravet Syndrome tracked by BioSniper.